{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:07:40Z","timestamp":1789247260276,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","award":["SKL-HIDCA-2024-BZ18"],"award-info":[{"award-number":["SKL-HIDCA-2024-BZ18"]}],"id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","award":["SKL-HIDCA-2024-1"],"award-info":[{"award-number":["SKL-HIDCA-2024-1"]}],"id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","award":["SKL-HIDCA-2024-BZ5"],"award-info":[{"award-number":["SKL-HIDCA-2024-BZ5"]}],"id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tice.2026.103686","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:41:05Z","timestamp":1781019665000},"page":"103686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CD44 gene rs9666607 polymorphism is associated with papillary thyroid carcinoma and interacts with CREB3L1"],"prefix":"10.1016","volume":"103","author":[{"given":"Lili","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borong","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.tice.2026.103686_bib1","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1097\/CM9.0000000000003284","article-title":"Global burden of thyroid cancer in 2022: incidence and mortality estimate from GLOBOCAN","volume":"137","author":"Lyu","year":"2024","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib2","article-title":"Temporal trends of thyroid cancer in China and globally from 1990 to 2021: an analysis of the global burden of disease study 2021","volume":"14","author":"Huang","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"18","key":"10.1016\/j.tice.2026.103686_bib4","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1158\/0008-5472.CAN-20-3334","article-title":"Multiparametric photoacoustic analysis of human thyroid cancers in vivo","volume":"81","author":"Kim","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","article-title":"High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell. Death Discov."},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib6","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/s41467-024-47581-1","article-title":"Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks","volume":"15","author":"Qu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2026.103686_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217069","article-title":"CircPCNXL2 promotes papillary thyroid carcinoma progression by regulating fatty acid metabolism induced by anabolic enzyme ACC1","volume":"598","author":"Chu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2026.103686_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2087204","article-title":"The Importance of CD44 as a stem cell biomarker and therapeutic target in cancer","volume":"2016","author":"Thapa","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.tice.2026.103686_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113872","article-title":"CD44-targeted RIP3 gene delivery strategy for enhanced cancer therapy via necroptosis and immune modulation","volume":"384","author":"Kim","year":"2025","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.tice.2026.103686_bib10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/bios15120796","article-title":"Digging into the solubility factor in cancer diagnosis: a case of soluble CD44 protein","volume":"15","author":"Myrkhiyeva","year":"2025","journal-title":"Biosens."},{"issue":"12","key":"10.1016\/j.tice.2026.103686_bib11","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2009-09-238782","article-title":"CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation","volume":"115","author":"Hu","year":"2010","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.tice.2026.103686_bib12","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.3390\/ijms26178223","article-title":"Expression of CD44 and its spliced variants: innate and inducible roles in nervous tissue cells and their environment","volume":"26","author":"Geloso","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.tice.2026.103686_bib13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/cancers16081569","article-title":"CD44: a new prognostic marker in colorectal cancer?","volume":"16","author":"Ziranu","year":"2024","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.tice.2026.103686_bib14","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.3390\/ijms242115812","article-title":"The hyaluronan\/CD44 Axis: a double-edged sword in cancer","volume":"24","author":"Cirillo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.tice.2026.103686_bib15","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1111\/febs.16179","article-title":"The state of CD44 activation in cancer progression and therapeutic targeting","volume":"289","author":"Guo","year":"2022","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.tice.2026.103686_bib16","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/molecules30091899","article-title":"CD44 variant expression in follicular cell-derived thyroid cancers: implications for overcoming multidrug resistance","volume":"30","author":"Mosoane","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.tice.2026.103686_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fimmu.2015.00182","article-title":"The role of CD44 in disease pathophysiology and targeted treatment","volume":"6","author":"Jordan","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tice.2026.103686_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcp.1041640319","article-title":"Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells","volume":"164","author":"Welsh","year":"1995","journal-title":"J. Cell. Physiol."},{"issue":"22","key":"10.1016\/j.tice.2026.103686_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202001417","article-title":"CDK5 inhibition abrogates tnbc stem-cell property and enhances anti-PD-1 therapy","volume":"7","author":"Bei","year":"2020","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.tice.2026.103686_bib20","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.7150\/thno.109534","article-title":"Erratum: redox regulation of stem-like cells though the cd44v-xct axis in colorectal cancer: mechanisms and therapeutic implications: erratum","volume":"15","author":"Ju","year":"2025","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.tice.2026.103686_bib21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00535-025-02272-6","article-title":"aGenome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alternative splicing","volume":"60","author":"Lei","year":"2025","journal-title":"J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.tice.2026.103686_bib22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ymthe.2020.02.016","article-title":"Oncolytic adenovirus armed with bite, cytokine, and checkpoint inhibitor enables car t cells to control the growth of heterogeneous tumors","volume":"28","author":"Porter","year":"2020","journal-title":"Mol. Ther."},{"issue":"35","key":"10.1016\/j.tice.2026.103686_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210732","article-title":"Photostable cascade-activatable peptide self-assembly on a cancer cell membrane for high-performance identification of human bladder cancer","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tice.2026.103686_bib24","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.2147\/IJN.S529250","article-title":"Combined hyaluronic acid nanobioconjugates impair cd44-signaling for effective treatment against obesity: a review of comparison with other actors","volume":"20","author":"Uti","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.tice.2026.103686_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3892\/ol.2025.15013","article-title":"Regulatory SNP of TERT promoter accompanied by C228T and BRAFV600E is an exacerbating factor of papillary thyroid carcinoma","volume":"29","author":"Nakazato","year":"2025","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.tice.2026.103686_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/carcin\/bgy062","article-title":"Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival","volume":"39","author":"Freedman","year":"2018","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10238-026-02101-x","article-title":"CD44 is associated with papillary thyroid carcinoma metastasis via potential modulation of the immunosuppressive tumor microenvironment","volume":"26","author":"Adeerjiang","year":"2026","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","article-title":"CD44 as a tumor biomarker and therapeutic target","volume":"9","author":"Xu","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.tice.2026.103686_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tem.2022.02.002","article-title":"The membrane receptor CD44: novel insights into metabolism","volume":"33","author":"Weng","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.tice.2026.103686_bib30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","article-title":"CD44 regulates epigenetic plasticity by mediating iron endocytosis","volume":"12","author":"M\u00fcller","year":"2020","journal-title":"Nat. Chem."},{"issue":"20","key":"10.1016\/j.tice.2026.103686_bib31","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.3390\/cancers15205041","article-title":"CD44 intracellular domain: a long tale of a short tail","volume":"15","author":"Skandalis","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2026.103686_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108374","article-title":"CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations","volume":"787","author":"Gomari","year":"2021","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"3","key":"10.1016\/j.tice.2026.103686_bib33","doi-asserted-by":"crossref","DOI":"10.31083\/FBL24821","article-title":"CD44 and its role in solid cancers - a review: from tumor progression to prognosis and targeted therapy","volume":"30","author":"Gama","year":"2025","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.tice.2026.103686_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.tice.2026.103686_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/thy.2018.0547","article-title":"Multifocality is not an independent prognostic factor in papillary thyroid cancer: a propensity score-matching analysis","volume":"29","author":"Geron","year":"2019","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.tice.2026.103686_bib36","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1210\/jc.2017-00277","article-title":"The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer","volume":"102","author":"Wang","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.tice.2026.103686_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tice.2026.103686_bib38","first-page":"1263","article-title":"Unique SNP in CD44 intron 1 and its role in breast cancer development","volume":"30","author":"Zhou","year":"2010","journal-title":"Anticancer. Res."},{"issue":"12","key":"10.1016\/j.tice.2026.103686_bib39","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/biom11121850","article-title":"CD44: a multifunctional mediator of cancer progression","volume":"11","author":"Hassn Mesrati","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-12805-x","article-title":"LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis","volume":"15","author":"Hejazi","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.tice.2026.103686_bib41","first-page":"4693","article-title":"p63 inhibits CD44+\/CD24- cell proliferation and chemoresistance in papillary thyroid carcinoma cells","volume":"14","author":"Guo","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"24","key":"10.1016\/j.tice.2026.103686_bib42","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1158\/1078-0432.CCR-16-0058","article-title":"CD44 SNPrs187115: a novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma","volume":"22","author":"Stracquadanio","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2026.103686_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12935-018-0522-2","article-title":"Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis","volume":"18","author":"Esmaeili","year":"2018","journal-title":"Cancer Cell. Int."},{"issue":"5","key":"10.1016\/j.tice.2026.103686_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0961203319838063","article-title":"CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients","volume":"28","author":"Novelli","year":"2019","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.tice.2026.103686_bib45","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/09612033211004725","article-title":"mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients","volume":"30","author":"Latini","year":"2021","journal-title":"Lupus"},{"issue":"31","key":"10.1016\/j.tice.2026.103686_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis","volume":"7","author":"Luo","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.tice.2026.103686_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12943-022-01658-x","article-title":"CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2026.103686_bib48","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41467-017-01052-y","article-title":"Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1","volume":"8","author":"Feng","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:20:08Z","timestamp":1789244408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"alternative-id":["S0040816626003800"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103686","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD44 gene rs9666607 polymorphism is associated with papillary thyroid carcinoma and interacts with CREB3L1","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103686"}}